Xtent (a licencee of Biosensors) share price rose almost 10 times from ~$0.25 to $2.5 after it reported that it received the IDA approval from FDA in 2 days.
Yoh, anjan? wat animal? AK presumes u meant anjing(dog). On d other hand if u think that anjan is duck(itek,itik) u sure kena hantam one, buy our Malay's forumers. He he.
louis_leecs ( Date: 05-Jun-2009 09:08) Posted:
ayam and anjan all can fly,,,,,,,,,,,,,,tis baby hoot liao ah,,,,,,,,,,,,,,,chiong ah
tis baby look like rowsley,,,,,,,,,,,,,,,,,,,,fewer buy and huge selling,,,,,,,,,,,,,,,,,,,even clear the selling block then heavy selling apear again,,,,,,,,,,,,,,,,,,,,,,,just like someone heavy guard scar the weak holder,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,so patience wait,,,,,,,,,,,,,,,,and after tis you will see the action coming,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,this is a buy and hold period,,,,,,,,,,,,,,,,,no contra,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,otherwise vyou will lose you panty,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,believe bb from gg is around tis area,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cheeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeers
im still hold tight tight,,,,,,,,,,im happy someone keep hightlight me.........thank you to promote me,,,,,,,,,,,,domo aligato,,,,,,,,,,,,,,,,,im strong believe tis baby goint to test 72cts,,,,,,,,,,,,,,,,,,,,now my ah moh and ocbc remiser tell me accumulate wait for unforseen akan datang surge,,,,,,,,,,,,,,,,,,trust me,,,,,,,,the day akan datang,,,,,,,,,,,,,,,,,,,,,cheeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeers
For Info Only - Xtent also has received IDE from the FDA.
Jun 4, 2009,
XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
MENLO PARK, Calif., June 4, 2009 /PRNewswire-FirstCall via COMTEX/ -- XTENT, Inc. /quotes/comstock/15*!xtnt/quotes/nls/xtnt (XTNT 0.65, +0.35, +116.45%) today announced that the Company received conditional approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) authorizing it to begin its pivotal clinical program, composed of two pivotal trials called CUSTOM IV and CUSTOM IV Angio to support the approval in the United States of its Custom NX(R) Drug Eluting Stent (DES) System. The conditional approval requires the Company to address some technical issues about which the FDA has questions prior to granting full approval.
"This conditional approval further demonstrates the progress made in the development of a truly revolutionary drug eluting stent system," said Greg Casciaro, President and Chief Executive Officer of XTENT, Inc. "I want to recognize each and every XTENT employee, and especially Dr. Philippe Marco, our Vice President of Quality Assurance, Clinical and Regulatory Affairs, for their dedication and efforts in introducing a new drug and coating formulation along with a new delivery platform through this regulatory process. We also must credit the active participation and support of our BA-9/PLA licensor, Biosensors."
"This is a significant milestone for a technology that was designed to treat today's complex patient population that presents with multi-vessel coronary artery disease and/or long lesions," said Martin B. Leon, M.D., Associate Director of the Center for Interventional Vascular Therapy, New York-Presbyterian Hospital/Columbia University Medical Center. "It will be a missed opportunity if this technology does not carry forward in development quickly as it not only potentially fills the unmet clinical needs we have today, but it may also address the increasing cost pressures faced by the global healthcare system by potentially reducing the total procedural cost for coronary stenting."
"This is a bitter sweet announcement because of the timing," added Casciaro. "Although the Company's Board of Directors has approved a plan of complete liquidation and dissolution, we will continue to consider any reasonable alternative strategic proposals presented to us prior to the upcoming shareholder meeting."
The Company previously announced on May 15, 2009 that its board of directors has unanimously approved a plan of complete liquidation and dissolution of the Company subject to stockholder approval. XTENT intends to hold a special meeting of stockholders on July 9, 2009 at its principal offices located at 125 Constitution Drive,
may be termasek tomorow wake up tis baby,,,,,,,,,,,,,and say im interest you,,,,,,,,,,,,,,,,,,,,,,,,then we huat liao,,,,,,,,,,,,,,,,,,,,hope may be the day is coming,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,i just say may be and pray hard,,,,,,,,,,,,,,,,,,,,,biosensors break thru 60cts,,,,,,,,,,,,,,,,,now i rais target to 72cts,,,,,,,,,,,,,,,,,,,,,,,,,,,,the chart sui sui akan datang,,,,,,,,,,,,,,,,,,,,,,,,patien wait,,,,,,,,,,,,,,,,,,we will reward,,,,,,,,,,,,,,,,,,,,cheeeeeeeeeeeeeeeeeeeeeeeeeeeeeeers ,,,$$$$$
I am selling most counters for profits to collect BIG. Strongly believe the day will come for BIG to Cheong Big. They say "Everydog has its day." So I think this BIG Doc will have its day too, and soon.
I think traders and investors are accumulating Biosensors stocks at around $0.53 to $0.55 level. My gut feel is that they will push it back to the high of $0.585 or even further within this week.
weak holder all out,,,,,,,,,,,,,,the ah moh remiser tell me,,,,,,,,,,,,,,,,fill the bottom now tis having a good time to come ,,,,,,,,,,,,,,,,,,,,,,,,,,the one press down tis tis baby is from p hse,,,,,,,,,,,,,,,,,,,,,,,,,,,,now is a good chances to reloaded more for me,,,,,,,,,,,,,,,,,,,,,,,so far i not going to abandone tis baby,,,,,,,,,,,,,,,,,,i going to buy more from other hse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,now i more confident with ah moh remiser better rhan local hse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,tis baby going to powerful rally catch up after weak holder out.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,cheers
Post Reply
4621-4640 of 10899
